Some of the potential therapies of stem cells would require amplification of samples (technically possible now), raising the possibility of multiple uses within a family unit. There is now so much research being undertaken and reported we frequently find ourselves contradicting patients that it is not a panacea and that much of the research has many years before therapies arise from the work.

Areas which are rapidly gathering scientific credibility as therapies of the future that would involve stem cell collection and storage include organ engineering and repair and neurological damage repair, as well as Diabetes. Its widespread use for certain malignancies is currently not recommended. However, there is every possibility that this scenario will change. We feel that cord blood stem cell storage will have a growing therapeutic role in the short future. We feel strongly that private cord blood storage should be offered with full counselling of the risks, limitations and benefits as part of an informed consent process, but also that women are entitled to have access to information to allow them to make this decision based on unbiased factual information about stem cells and cord blood collection.

–About–
Director of Cells4Life Ltd - Experts in stem cells storage and cord blood collection. Please visit: www.cells4life.co.uk.
Source: ArticleTrader.com

Mesa resident Susan Jarvis-Orr is among those who believe more parents should privately store or donate cord blood to a public bank. She credits cord blood stored at CBR after the birth of her third son, Devyn, with saving the life of her first son, Brandyn. Brandyn received a blood transplant in 1999 after a particularly rough stretch of chemotherapy to treat his leukemia. The radiation destroyed cancer and stem cells alike, so Brandyn’s transplant of stored stem cells allowed him to replenish his blood supply. Brandyn, now 13, is a healthy boy, helping his mother swap out ceiling fans at rental properties and capturing a Young Hero award from the Fire Department for performing the Heimlich maneuver on a choking woman. “Many people don’t realize how important this is,” Jarvis-Orr said. “You can save someone’s life.”

Mesa resident Susan Jarvis-Orr is among those who believe more parents should privately store or donate cord blood to a public bank. She credits cord blood stored at CBR after the birth of her third son, Devyn, with saving the life of her first son, Brandyn. Brandyn received a blood transplant in 1999 after a particularly rough stretch of chemotherapy to treat his leukemia. The radiation destroyed cancer and stem cells alike, so Brandyn’s transplant of stored stem cells allowed him to replenish his blood supply. Brandyn, now 13, is a healthy boy, helping his mother swap out ceiling fans at rental properties and capturing a Young Hero award from the Fire Department for performing the Heimlich maneuver on a choking woman. “Many people don’t realize how important this is,” Jarvis-Orr said. “You can save someone’s life.”

The first thing you should know, and probably already do, is that stem cell research is not as new a phenomenon as you might think. A bone marrow transplant is successful because it replaces stem cells within the patient using the stem cells found in the bone marrow from the donor. The morality of embryonic stem cell research does not apply to umbilical cord stem cell research.

Often, discussions of stem cell research break down into an argument regarding the ethical use of embryonic stem cells; however, it is important to differentiate between embryonic stem cells and umbilical cord stem cells.

The retrieval of embryonic stem cells leads to the destruction of the embryo, however, umbilical cord blood can be taken once the birth is completed and the umbilical cord has been clamped and cut as usual.

The birth and mother and baby are unaffected by the procedure making it completely harmless to all concerned. Another important point is that when researchers talk about umbilical cord blood they are also referring to blood taken from the placenta, otherwise known as the afterbirth. Again, the extraction of this blood is carried out only once the birth is completed and at a time when the cord and the placenta would normally be disposed of.

History of the use of flexible stem cells + placenta.

Bone marrow transplants have been carried out for more than 30 years and with exceptionally good results but that doesn’t mean that the process is faultless. The extraction of bone marrow is a complicated procedure that is intrusive to the donor. The procedure is painful and can result in recovery time stemming over several weeks. Also, there are comparatively few donors willing to donate bone marrow because of this fact.

Most patients who have a bone marrow transplant find that their best chance of finding a donor is through a sibling or other relative. This is because the marrow and the stem cells must be a match with the patient.

A list of criteria is drawn up and the more boxes that can be ticked the greater the match and subsequently the less chance there is that the body will reject the new tissue. Tissue rejection can lead to a worsening of the patient’s condition so it is important that marrow transplants only occur when a good match is found.

Why umbilical cord stem cell transplants?

The umbilical cord blood transplants utilize cord blood that is high in primitive stem cells. These stem cells are not only more able to transform into other cells but are also much more likely to be accepted by the patient’s body and immune system. This is essentially because they are seen as less of a threat than adult stem cells found in adult’s bone marrow.

Currently one of the big adult stem cells cons and gives light to research being carried out on diseases other than those that a bone marrow transplant can help, and early indications show that an umbilical cord blood transplant could be the answer to heart failure and many other deadly diseases.

Overall the picture of umbilical cord stem cell research is a positive picture and with more donations of cord blood further research can be conducted and more uses for the stem cells derived from cord blood can be developed.

–About–
For more information on cord blood banking, visit Blood Cord Bank.
Source: ArticleTrader.com

Clara Chestnut from California has just become one of only a handful who have received her second treatment of adult stem cells for her failing heart. “I’ve been going downhill since 2000, with every year more of my heart being dead,” she said. “But after my first treatment in April 2006 my cardiologists have done a huge attitude shift and now recognize that ‘No change’ is a certificate of my wellbeing. Staying the same is terrific, so if it takes coming back every year I will do that.”

Like many heart patients Clara had experienced several heart attacks without knowing what they were. Her doctor concurred that at 59 the pains she experienced were probably arthritis, so she started carrying her purse on the other arm, but it made no difference. Then in 2000 she had two major heart attacks and started on the downhill slide. Specialists gave her 30days to live without a bypass and also told her she probably would not survive the surgery.

Clara got mad and searched until she found someone who could help her. “I wasn’t ready to die, and I knew that someone, somewhere, knew more than those people,” she said. Her new doctor gave her the first of seven stents and she felt “wonderful”. She read about singer Don Ho and his success story with VesCell adult stem cells, so did her research and in the face of her doctors’ opposition went to Bangkok in the care of TheraVitae, a leading international biotechnology company whose product, VesCell, has now helped hundreds of heart failure and PAD patients. “I was most impressed with the professionalism of the doctors and the nursing staff. Everything went fine and the following February I returned to my specialist for a cardiogram. He told me nothing had changed, so I asked him ‘Would you go back to Bangkok if you were me?’ He said that he would, but that I didn’t have to leave the next morning! That is an enormous attitude change.”

People looking for hope and help, who want to feel better and be more active, are the most outspoken advocates of adult stem cell therapy. “I listen to myself and I feel anybody with any sense would listen to themselves and know it’s something they should do. They know how they are feeling. They know how wonderful it would be to feel better. I don’t see why anybody would be reluctant,” she said.

–About–
Jon Bradshaw writes constantly about the next to miraculous effects of adult stem cells. Theravitae’s Vescell adult stem cells the new frontier of regenerative medicine. They offer a return to a more active, longer and healthier life to patients who have heart disease or PAD. They are derived from the patient’s own blood so cannot be rejected by the body.
Source: ArticleTrader.com

‘CHA Group Stem Cell Institute’ has not only research facilities such as stem cell institute, GMP grade sterile culture room which can make the medicines, cord blood bank, immunity vaccine institute, artificial internal organ institute but also life science school, medical school to train professionals. After Stem cell institute is completed, it will be
equipped with Lab to Patient System which can pursue clinical demonstration at Bundang CHA Hospital immediately from latest research. And it is expected to joint research with the world’s leading research institute in the stem cell institute. They planned to promote cooperating with the world’s famous stem cell institute such as UCLA(University of California at Los Angeles), Columbia University, Alabama State University , Rice University, University of Southern California, Cedars-Sinai Medical Center, Harvard University McLean Hospital etc.

And few months ago, College of Medicine, Pochon CHA University (representative: Kwang Yul Cha M.D) held “The 5th Pacific Rim Society for Fertility and Sterility” in Dynasty Hall, Seoul Shilla Hotel from June 9th~10th to conquer the low birth late, inviting the world’s foremost scholars in the field of sterilization and reproductive medicine. ‘The 5th Pacific
Rim Society for Fertility and Sterility’ held by CHA Medical Group(Representative : Kwang Yul Cha) is hosted by three leading institute; The Korean Society of Fertility & Sterility, The Korean Society of preservative reproductive medicine, and The Korean Society of Developmetal Biology. Nationally and internationally well-known authorities on the field of Sterilization and reproductive medicine from Korea, United States, and Japan announced their papers and about 500 participants from Thailand, India, Vietnam and Nepal enlighten the conference.

At first day of the conference, representative Cha Kwang Yul read the paper ‘Slush Nitrogen Ovum Freezing method’ that received ‘The Best Paper Award’ from ‘World Society for Reproductive Medicine’ and the head manager of Stem Cell Institute, Hyung-Min Jung made presentation over embryonic cell and was greeted enthusiastically by the participants. The
survival rate of ovum is about 50 percents when applying the Existing Ovum Freezing Method. On the other hand, Slush-Nitrogen Ovum Freezing Method raise the survival rate to over 90 percents that it initiated the way to activate the ovum bank.

Stem Cell Production Capacity: CHA Medical Group(representative: Kwang Yul Cha) created total 12 Human Embryonic Stem Cell and under the admission of the International Stem Cell Deliberate Council, CHA Medical Group(representative: Kwang Yul Cha) is planning to produce over 100 embryonic stem cell that are able to apply clinical demonstration using human
supporting cell, serum and non-serum culture medium at GMP within 10 years.

World known cytogenesis capacity & ability: CHA Medical Group(representative: Kwang Yul Cha) is the first to success in recovering the damage of cranial nerves by transplanting the mice’s embyonic stem cell into alive one’s brain. Developed differentiation technology by using neuron, vascular Endothelial, Cartilage Cell, Endocrine Cell, and Heart muscle cells.

Gene Manipulation in Human embryonic stem cell: By developing technology that can induct specific gene into Human Embryonic Cell CHA Medical Group achieved cytogeny technology in specific cell, Human Embryonic Stem Cell production, medicinal screening method, Tumor Suppressor Technology, and interpreting the function of the specific gene.

Gene Therapy ability: Found cancer cell suppressor protein and enzyme gene called ‘mHAUSP’ that operates the cancer-suppressing activity. Now researches on therapy and clinical test on progressing.

Artificial organ production ability: By Utilizing embryonic stem call and adult stem cell developed biodegradable tissue, instestine and Scaffold, Researches on three-dimensional artificial tissue and intestine production is in advance.

Leading the Cell Therapy Product market using stem cell: If applied-technology such as cytogenesis and cell therapy utilizing embryonic stem cell is practically use, size of over 600 billion won market will be created. To treat specific diseases( Leukemia, Diabetes, urinary incontinece, stroke) cell differentiation inducement and establishing stem cell
lines bank using Embryonic Stem Cell and Adult Stem Cell is promoted.

Researches on Sterility & Stem Cell Security is guarantteed by running ‘Human Ovum Freezing Bank: ‘Slushed-Nitrogen Ovum Freezing Method’ has survival rate over 90 percents and pregnancy rate is over 65%, too. The method described above is known as world’s best technology that has similiar reproduction ability to general ovum. CHA Biotec (Board of
Director:Kwang Yul Cha) became the leader of this field by steadily executing safe and moral stem cell and medical treatment on sterility by running freezing bank.

CHA Regenerative Medical Institute, awarded the grant “Patient-Specific Stem Cell Production”: Awarded the grant related to patient-specific stem cell production using somac cell reproduction from WIRB in June, 2006. Using Human ovum Freezing Bank, developing patient-specific stem cell production and treatment techonology is their aim.

–About–
Kwang Yul Cha is certified Obstetrics and Gynecology by College of Medicine, Yonsei University-Board. He is the president of Infertility Medical Center, CHA General Hospital, Chancellor of the College of Medicine, Pochon CHA University and Professor of the Department of Obstetrics and Gynecology. College of Medicine, Columbia University. Kwang Yul Cha Published over 100 articles in peer-reviewed scientific journals.
Source: ArticleTrader.com

Consider the case of the Miltos family, whose two children, Nathan and Phil Joseph (P.J). are affected with a condition called Late Infantile Batten Disease. It’s the most common form of a group of disorders called neuronal ceroid lipofuscinoses. Affected children like Nathan and P.J. lack a specific enzyme necessary to eliminate cellular waste. The accumulation of toxic material leads to death of neurons, resulting in mental impairment, worsening seizures and progressive loss of sight and motor skills. It’s always fatal; most children do not live past 12 years of age. This untreatable genetic condition, occurs in about three of every 100,000 births in the United States.

Researchers hope to someday inject adult stem cells into the suffering child’s central nervous system (CNS). Once injected, in theory, the cells would produce an enzyme to help the CNS to regain function. Adult stem cell therapy has shown tremendous promise for growing neurons to “re-build” a diseased brain. Dr. William Mobley, chairman of the Department of Neurology at Stanford University explains, “It’s the loss of brain cells that leads to the neurodegenerative disease process. If you provide host cells with something that sustains them, you may be able to cure or at least delay the onset of the disease.” The potential for manipulating stem cells to repair or replace diseased or damaged tissue has generated a great deal of excitement in the scientific and medical communities.

One company, StemCells, Inc., is engaged in identifying and isolating stem cells from a variety of medically important tissues, including the brain, liver and pancreas. Phil Milto, the father of Nathan and P.J., and President of the Nathan’s Battle Foundation for Late Infantile NCL Therapy Development says, “StemCells Inc.’s recent data is the most promising cell mediated data we have seen. The results are extremely encouraging for Batten’s disease and potentially for all neurodegenerative disorders. Preliminary results showed a large area of new cell activity.”

With its strong research and successful culturing of human neural stem cells, the company, experts say, is poised to become a leader in novel treatments of diseases characterized by damage to or degeneration of the CNS as well as treatments for disorders of the liver and pancreas.

To learn more about stem cell therapy, look online at www.stemcellsinc.com. To learn more about Batten disease, see www.nathansbattle.com or www.bdsra.org.

Courtesy of ARA Content

–About–

Courtesy of ARA Content

Source: ArticleTrader.com

Cord Blood is the blood that remains in the umbilical cord and placenta following birth. Cord Blood is routinely discarded with the placenta and umbilical cord. The blood in the cord is a rich source of stem cells. Stem cells are the building blocks of your blood and immune system. Stem cells have the ability to differentiate into other types of cells in the body, and thus give rise to all the tissues, organs and systems in the body. The stems cells in a child’s cord blood are genetically unique to the baby and its biological family.

Due to stem cells ability to differentiate into other types of cell tissue in the body, treatments can be developed for diseases such as Parkinson’s, Alzheimer’s and Diabetes to name a few. Stem cells found in the cord blood are a valuable biological resource that researchers can use to investigate the potential of future applications for cord blood stem cells.

Cord Blood Banking

Cord Blood Banking is the process whereby umbilical cord blood stem cells are saved for potential medical uses. Cord blood banking includes the processes of collection, processing and storing of the umbilical cord blood. Collection involves drawing the cord blood from the umbilical cord, using either the syringe or bag collection method, after the umbilical cord has been clamped and cut. Processing involves the testing of the cord blood to determine whether it meets eligibility standards and removing and red blood cells or plasma that will not be needed in transplantation. Storage involves storing the cord blood unit in a vinyl or plastic bag in which it is frozen in liquid nitrogen.

There are two types of cord blood banks. Firstly there are the family banks, which store the umbilical cord for one’s own family use. Secondly, there are the public donor banks, which store the umbilical cord blood for unrelated or non-family use - which is public use. Every parent has the option of saving their baby’s cord blood for their family use, while only a small number of people may be able to donate their baby’s cord blood stem cells.

Cord Blood Stem Cells

There are three sources of stem cells: bone marrow, peripheral blood (that is the blood that circulates through the body) and umbilical cord blood. Cord blood stem cells, however, are different from other types of stem cells. By freezing these cells, any aging or damage to these cells is prevented, that usually occurs later in life. Umbilical cord blood stem cells are also more proliferate than adult stem cells, such as those found in bone marrow.

The information contained in this article is for educational purposes only and is not intended to medically diagnose, treat or cure any disease. Consult a health care practitioner before beginning any health care program.

–About–

Emily Clark is editor at Lifestyle Health News and Medical Health News where you can find the most up-to-date advice and information on topical health matters.

Source: ArticleTrader.com

Four years ago Buck Brumble was walking four miles a day and enjoying rambling around parks and beaches. Three months ago he was so weak he could not walk around the block.

He had never had a heart attack and his arteries were as clean as a whistle but his heart muscle had been progressively weakened by dilated cardiomyopathy until his Ejection Fraction was a mere 20.

Like many cardiomyopathy patients Buck had tried many different medications but he knew he was slipping. He heard about Theravitae, a multi-national biotechnology company and its product VesCell, from a friend who had read of their staggering success in returning no-option heart patients to a more active, longer and healthier life using their own adult stem cells. Buck did his research and blest with supportive friends and doctors traveled to Bangkok to get his quality of life back.

The hospital here is so modern, so well coordinated that everything just flowed, he said. Everybody was so willing to help and so kind and cheerful that it made the whole experience just fine. My advice to others with cardiomyopathy is not to delay because the longer you wait the weaker you get. I couldn’t be more loved and supported and I hope I can help others the way I have been helped.

VesCell adult stem cell therapy is used by cardiologists and vascular surgeons to treat heart disease for no-option patients suffering from Coronary Artery Disease (Coronary Heart Disease), Cardiomyopathy, and Congestive Heart Failure.

The adult stem cells are derived from the patient’s own blood, so there is no possibility of the body rejecting its own stem cells. This makes the procedure very safe.

Our adult stem cell therapy can relieve debilitating symptoms such as severe angina pectoris (chest pain), lack of energy and shortness of breath and thereby reduce dependence on nitro tablets. Patients who have exhausted all other treatment options such as a cardiac artery bypass graft (CABG) or balloon angioplasties (PTCAs) are candidates.

VesCell stem cell therapy for heart disease creates new blood vessels that improve blood flow to the heart as well as generate new tissue in the heart muscle itself. The stem cell therapy leads to an increased ability to do everyday tasks, a noticeable increase in energy and hence an enhanced quality of life for the majority of our patients.

–About–
Jon Bradshaw writes constantly about the next to miraculous effects of adult stem cells. Theravitae’s Vescell adult stem cells the new frontier of regenerative medicine. They offer a return to a more active, longer and healthier life to patients who have heart disease or PAD. They are derived from the patient’s own blood so cannot be rejected by the body.
Source: ArticleTrader.com

So what are they?

Stem Cells are master cells, meaning that they can generate many, if not all, of the different tissues of the body. They are with us our entire lives and are released naturally from the bone marrow, but like everything else, the process behind their release slows down with age. When there aren’t as many stem cells in the blood stream, the body can’t repair and renew itself as it once did. These master cells are still contained in the bone marrow in the millions, just not being released as they should.

As this natural release occurs we need to concern ourselves with finding ways to reverse it. The good news is there are 4 things we can do.

Exercise - as we already know, regular exercise is vital to good health
Proper breathing - deep breathing oxygenates the blood and tissues
Good Nutrition - we need nutrients to nourish and water to flush toxins from our cells
Stem cell enhancers - a new product category set to become what antioxidants are today

Stem Cells are the only known source for rebuilding the body and renewing health by restoring lost or degraded cells. They have already been used to help treat things such as Leukemia, AIDS, Alzheimer’s Disease and multiple sclerosis.

They have been used to form new cartilage, grow new corneas to restore sight to the blind, as treatments for stroke victims, and several groups are using adult stem cells with patients to repair damage after heart attacks.

Early clinical trials have also shown initial success in patient treatments for Parkinson’s disease and spinal cord injury. And, the first FDA-approved trial to treat juvenile diabetes in human patients is ready to begin at Harvard Medical School, using adult stem cells. In short, they are the building blocks of life itself.

Adult versus Embryonic Stem Cells.

Adult Stem Cells is the term given to stem cells after birth which means babies have adult stem cells in their bodies. Embryonic stem cells are simply those from embryos — undifferentiated, or not developed into a specific cell types. Research has shown that embryonic stem cells can develop genetic abnormalities. This is not the case with our own adult stem cells.

For this reason, researchers such as Kursad Turksen in his book ‘Adult Stem Cells’ offer the following wisdom: “Adult stem cell biology is at the forefront of the emerging field of regenerative medicine, offering a source of cells to generate tissues that lack some of the ethical and political impediments inherent in embryonic, fetal, and cloned cells.”

The biggest advantage of using adult stem cells is that the body’s own stem cells can be used, effectively removing the problems of immune rejection or abnormalities.

Adult stem cell science is real.

Adult stem cell research offers the best and clinically proven treatments for a whole host of human diseases and conditions and is helping people overcome these health challenges as you read this article. There are currently over 700 FDA approved clinical trials going on in the United States using adult stem cells but none for embryonic stem cells which is why the future of regenerative health and wellness looks great with Adult stem cells.

–About–
Matt Canham runs http://adult-stem-cells.info, a site dedicated to informing people about how increasing the number of adult stem cells circulating in the blood stream can help maintain optimal health.
Source: ArticleTrader.com